Comparative analysis of HIV-1-based lentiviral vectors bearing lyssavirus glycoproteins for neuronal gene transfer

[1]  M. Federico.  Lentivirus Gene Engineering Protocols , 2010, Methods in Molecular Biology.

[2]  R. Kutner,et al.  A comparative analysis of constitutive and cell‐specific promoters in the adult mouse hippocampus using lentivirus vector‐mediated gene transfer , 2008, The journal of gene medicine.

[3]  R. Kutner,et al.  Optimized lentiviral transduction of mouse bone marrow-derived mesenchymal stem cells. , 2008, Stem cells and development.

[4]  Kazuto Kobayashi,et al.  Efficient gene transfer via retrograde transport in rodent and primate brains using a human immunodeficiency virus type 1-based vector pseudotyped with rabies virus glycoprotein. , 2007, Human gene therapy.

[5]  N. Boulis,et al.  Gene therapy for peripheral nervous system diseases. , 2007, Current gene therapy.

[6]  R. Kutner,et al.  Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study , 2007, BMC biotechnology.

[7]  Z. Tonar,et al.  Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain , 2007, Gene Therapy.

[8]  John R. Mascola,et al.  Gene transfer in humans using a conditionally replicating lentiviral vector , 2006, Proceedings of the National Academy of Sciences.

[9]  G. Mentis,et al.  Transduction of motor neurons and muscle fibers by intramuscular injection of HIV-1-based vectors pseudotyped with select rabies virus glycoproteins , 2006, Journal of Neuroscience Methods.

[10]  R. Mandel,et al.  Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  N. Boulis,et al.  Gene‐based treatment of motor neuron diseases , 2006, Muscle & nerve.

[12]  C. Lundberg,et al.  Lentiviral vectors for use in the central nervous system. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  N. Mazarakis,et al.  Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications. , 2005, Human gene therapy.

[14]  Xian-Yang Zhang,et al.  LSU Digital Commons LSU Digital Commons Altering the tropism of lentiviral vectors through pseudotyping Altering the tropism of lentiviral vectors through pseudotyping , 2022 .

[15]  J. Reiser,et al.  Tight control of transgene expression by lentivirus vectors containing second‐generation tetracycline‐responsive promoters , 2005, The journal of gene medicine.

[16]  E. Feldman,et al.  Short‐term hyperglycemia produces oxidative damage and apoptosis in neurons , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  L. Greensmith,et al.  Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model , 2005, Nature Medicine.

[18]  U. Monani,et al.  Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy. , 2004, The Journal of clinical investigation.

[19]  A. Logan,et al.  Factors influencing the titer and infectivity of lentiviral vectors. , 2004, Human gene therapy.

[20]  N. Mazarakis,et al.  Lentiviral vectors for treating and modeling human CNS disorders , 2004, The journal of gene medicine.

[21]  N. Boulis,et al.  Cervical spinal cord delivery of a rabies G protein pseudotyped lentiviral vector in the SOD-1 transgenic mouse. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. , 2004, Journal of neurosurgery. Spine.

[22]  P. Carmeliet,et al.  VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model , 2004, Nature.

[23]  R. Barber,et al.  Neuroprotection in a rat Parkinson model by GDNF gene therapy using EIAV vector , 2004, Neuroreport.

[24]  D. Anson,et al.  An improved β-galactosidase reporter gene , 2004 .

[25]  Xian-Yang Zhang,et al.  Transduction of Bone-Marrow-Derived Mesenchymal Stem Cells by Using Lentivirus Vectors Pseudotyped with Modified RD114 Envelope Glycoproteins , 2004, Journal of Virology.

[26]  N. Mazarakis,et al.  Transduction patterns of pseudotyped lentiviral vectors in the nervous system. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[27]  D. Anson,et al.  An improved beta-galactosidase reporter gene. , 2004, Journal of biotechnology.

[28]  M. During,et al.  Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector delivery , 2003, Neurobiology of Disease.

[29]  A. Lever,et al.  Lentiviral vectors for gene delivery to normal and demyelinated white matter , 2003, Glia.

[30]  J. Reiser,et al.  Small- to large-scale production of lentivirus vectors. , 2003, Methods in molecular biology.

[31]  G. Kobinger,et al.  Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[32]  K. Cornetta,et al.  Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods , 2002, Gene Therapy.

[33]  A. Kingsman,et al.  Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. , 2001, Human molecular genetics.

[34]  A. Ganser,et al.  Quantitative determination of lentiviral vector particle numbers by real-time PCR. , 2001, BioTechniques.

[35]  M. Prevost,et al.  Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  N. Tordo,et al.  Evidence of Two Lyssavirus Phylogroups with Distinct Pathogenicity and Immunogenicity , 2001, Journal of Virology.

[37]  B. Davidson,et al.  Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors , 2000, Neuroreport.

[38]  J. Reiser.  Production and concentration of pseudotyped HIV-1-based gene transfer vectors , 2000, Gene Therapy.

[39]  A. Kingsman,et al.  Stable gene transfer to the nervous system using a non-primate lentiviral vector , 1999, Gene Therapy.

[40]  E. Feldman,et al.  Characterization of adenoviral gene expression in spinal cord after remote vector delivery. , 1999, Neurosurgery.

[41]  B. Kieffer,et al.  Low‐affinity nerve‐growth factor receptor (P75NTR) can serve as a receptor for rabies virus , 1998, The EMBO journal.

[42]  Hideki Mochizuki,et al.  High-Titer Human Immunodeficiency Virus Type 1-Based Vector Systems for Gene Delivery into Nondividing Cells , 1998, Journal of Virology.

[43]  L Naldini,et al.  Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector , 1997, Journal of virology.

[44]  S. Karlsson,et al.  Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[45]  F. Gage,et al.  In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.

[46]  K. Conzelmann,et al.  Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles , 1995, Journal of virology.

[47]  T. Tabira,et al.  Neuroblastoma × spinal cord (NSC) hybrid cell lines resemble developing motor neurons , 1992, Developmental dynamics : an official publication of the American Association of Anatomists.

[48]  N. Tordo,et al.  Complete cloning and molecular organization of a rabies-related virus, Mokola virus. , 1989, The Journal of general virology.

[49]  R. Campenot,et al.  Development of sympathetic neurons in compartmentalized cultures. II. Local control of neurite survival by nerve growth factor. , 1982, Developmental biology.